BlackThorn Therapeutics Reports New Insights into Neurobehavioral Disorders at the 49th Annual Meeting of the Society for Neuroscience

SAN FRANCISCO--(BUSINESS WIRE)--BlackThorn Therapeutics, Inc., today announced that the company presented new data science research into the underlying biology of neurobehavioral disorders at the 49th annual meeting of the Society for Neuroscience (SfN) taking place October 19-23 in Chicago. “CNS drug discovery and development needs biology-based, data-driven strategies to achieve better treatment outcomes for people with neurobehavioral disorders,” said Bill Martin, Ph.D., BlackThorn’s chief e

Click to view original post